What is ZBRA's health score?

ZEBRA TECHNOLOGIES CORP (ZBRA) has a TradeApes health score of 59 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ZBRA's estimated fair value?

Based on our 5-year discounted cash flow model, ZEBRA TECHNOLOGIES CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ZBRA undervalued or overvalued?

Our model currently rates ZBRA as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ZBRA... Refresh in a moment for the full analysis.

ZEBRA TECHNOLOGIES CORP (ZBRA)

Technology Overvalued low mixed

$232.11

Updated: 2026-06-06

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

63 Healthy

Relative Value

55 Mixed

Capital Allocation

55 Mixed

Risk

70 Healthy

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Weak liquidity — current assets below current liabilities

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.